title: Do elevated glucocorticoids contribute to reduced cerebral expression of insulin-degrading enzyme in schizophrenia?
authors.forename: Hans-Gert
authors.initials: HG
authors.lastname: Bernstein
authors.forename: Uwe
authors.initials: U
authors.lastname: Lendeckel
authors.forename: Johann
authors.initials: J
authors.lastname: Steiner
authors.forename: Bernhard
authors.initials: B
authors.lastname: Bogerts
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects*; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D007339:Insulysin / Q000378:metabolism*; D008297:Male; D017397:Prefrontal Cortex / Q000187:drug effects*; D012559:Schizophrenia / Q000473:pathology*
chemical_list: D014150:Antipsychotic Agents; D007339:Insulysin; D006220:Haloperidol